EPISODE · Dec 1, 2016 · 36 MIN
B2B Product-Market Fit: Replacing a 120-Year-Old Eye Exam
from The SaaS Podcast - AI, Growth & Product-Market Fit for SaaS Founders · host Omer Khan
Since 1895, eye exams have worked the same way - lenses in front of your face, "which is better, one or two?" Aaron Dallek and his co-founder found B2B product-market fit by replacing the entire process with a computer screen and a smartphone. Opternative lets you take an eye exam at home, get a prescription reviewed by an ophthalmologist, and buy glasses or contacts anywhere you want. This vertical SaaS hit 100,000+ signups, maintained a 0.06% refund rate, and raised $9.5 million - all while fighting industry lobbying trying to shut them down. Opternative ran 1,500 side-by-side refractions to prove their industry-specific SaaS was statistically equivalent to traditional in-office testing. That clinical validation was the foundation for their SaaS product-market fit. Aaron Dallek is a serial entrepreneur who started his first business at 14. His co-founder, Dr. Steven Lee, had performed 20,000 refractions when a patient asked "Why can't we do this at home?" That question became Opternative - proving B2B product-market fit in healthcare takes longer than expected but produces extraordinary results. 🔑 Key Lessons 🎯 B2B product-market fit requires replacing broken paradigms, not improving them: Opternative did not make eye exams faster - they eliminated the lens-based method entirely with digital screens and smartphones, creating a new category. 🛠️ Validate B2B product-market fit with clinical rigor: Opternative ran 1,500 side-by-side refractions comparing their technology to traditional exams and proved statistical equivalency before scaling. 🤝 Partner with industry insiders for credibility in regulated markets: Aaron partnered with Dr. Steven Lee, an optometrist with 20,000 refractions of experience, giving the product clinical credibility a pure tech team could not achieve. 📉 Expect regulatory pushback when disrupting incumbents: Optometry trade groups lobbied to ban Opternative through state legislation, while ophthalmology groups supported it - requiring the team to fight on legal and political fronts. 💰 Use proof of concept to unlock funding rounds: Aaron self-funded the initial build, used the working prototype to raise a $1M seed round, and each subsequent round was funded by investors who saw clinical validation and customer traction. Chapters Introduction Aaron's entrepreneurial journey from age 14 Previous startups - carbon management, printer cartridges, Inc 5000 How Aaron met Dr. Steven Lee and joined Opternative How the online eye exam works Validating the idea with 1,500 refractions What the first version of the product looked like Technical challenges of building a digital eye exam Step-by-step walkthrough of the Opternative experience Accuracy and reliability - 0.06% refund rate Getting the first customers and beta testing Surprises from early user testing Why it took two and a half years to achieve B2B product-market fit Industry response - ophthalmology support vs. optometry opposition Funding journey - from self-funded to $9.5M raised Company size - 29 employees and 100K+ signups Patent protection for the digital eye exam technology Business model - free exam, paid prescriptions Lessons learned - everything takes longer than expected Lightning round Resources Full show notes: https://saasclub.io/132 Join 5,000+ SaaS founders: https://saasclub.io/email
NOW PLAYING
B2B Product-Market Fit: Replacing a 120-Year-Old Eye Exam
No transcript for this episode yet
Similar Episodes
No similar episodes found.